• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

A Clinical Comparison between 0.5% Levobupivacaine and 0.5% Levobupivacaine with Dexamethasone 8mg Combination under USG Guided Brachial Plexus Block by Supraclavicular Approach

    Dr. Anusha G Hiremath, Dr. Parimala, Dr. Jyothsna M, Dr. Devanand B .

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 926-933

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Regional anaesthesia has been preferred over general anaesthesia in many orthopaedic surgeries due to lack of associated complications in regional blocks. Increasing the duration of local anaesthetic action can obtain the desired effect of prolongation of the postoperative patient comfort. Many adjuvants to local anaesthetics such as epinephrine, clonidine, opioids, dexmedetomidine and also neostigmine have been tried. Recently, dexamethasone has been found to prolong postoperative analgesia, reducing the requirement of the local anaesthetic and also the side effect profile. Hence our study was conducted to analyse the efficacy of dexamethasone as an adjuvant drug to levobupivacaine. After institutional ethical committee approval, CTRI registration and patient consent, a double blinded randomised controlled study was conducted in 50 patients aged 18-65 years of ASA I&II undergoing upper limb surgeries distal to mid-humeral level over a period of 1year. The mean duration of postoperative analgesia in Group D was 1022.2±62.67 minutes and in Group S was 777.40±34.19 minutes (p<0.001). The mean total dose of rescue analgesics required was more in Group S when compared to Group D in the first 24hrs. The onset of sensory and motor block was faster in Group D when compared to Group S. The mean duration of sensory and motor block was significantly longer in Group D than Group S. The addition of dexamethasone to levobupivacaine in SCBP blockade was associated with faster onset as well as prolonged duration of sensory and motor block, prolonged duration of post-operative analgesia and required less rescue analgesics.
Keywords:
    Levobupivacaine dexamethasone Brachial plexus block Analgesia
  • PDF (457 K)
  • XML
(2023). A Clinical Comparison between 0.5% Levobupivacaine and 0.5% Levobupivacaine with Dexamethasone 8mg Combination under USG Guided Brachial Plexus Block by Supraclavicular Approach. European Journal of Molecular & Clinical Medicine, 10(2), 926-933.
Dr. Anusha G Hiremath, Dr. Parimala, Dr. Jyothsna M, Dr. Devanand B .. "A Clinical Comparison between 0.5% Levobupivacaine and 0.5% Levobupivacaine with Dexamethasone 8mg Combination under USG Guided Brachial Plexus Block by Supraclavicular Approach". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 926-933.
(2023). 'A Clinical Comparison between 0.5% Levobupivacaine and 0.5% Levobupivacaine with Dexamethasone 8mg Combination under USG Guided Brachial Plexus Block by Supraclavicular Approach', European Journal of Molecular & Clinical Medicine, 10(2), pp. 926-933.
A Clinical Comparison between 0.5% Levobupivacaine and 0.5% Levobupivacaine with Dexamethasone 8mg Combination under USG Guided Brachial Plexus Block by Supraclavicular Approach. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 926-933.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 23
  • PDF Download: 46
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus